The evolving landscape of immune-mediated glomerular diseases

Nature Reviews Nephrology, Published online: 14 December 2022; doi:10.1038/s41581-022-00666-wOver the past year, trial data have emerged on therapeutic interventions in IgA nephropathy and lupus nephritis, including the effects of different doses of glucocorticoids and several novel targeted therapies. These data, in combination with the discovery of autoantibodies targeting nephrin in minimal change disease, can inform the management of immune-mediated glomerular diseases.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Source Type: research